452 related articles for article (PubMed ID: 7698077)
21. Persistent, low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effect on aryl hydrocarbon receptor expression in a dioxin-resistance model.
Franc MA; Pohjanvirta R; Tuomisto J; Okey AB
Toxicol Appl Pharmacol; 2001 Aug; 175(1):43-53. PubMed ID: 11509025
[TBL] [Abstract][Full Text] [Related]
22. Species-specific binding of transformed Ah receptor to a dioxin responsive transcriptional enhancer.
Bank PA; Yao EF; Phelps CL; Harper PA; Denison MS
Eur J Pharmacol; 1992 Sep; 228(2-3):85-94. PubMed ID: 1332880
[TBL] [Abstract][Full Text] [Related]
23. A critical view of the mechanism(s) of toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Implications for human safety assessment.
Rozman K
Derm Beruf Umwelt; 1989; 37(3):81-92. PubMed ID: 2663408
[TBL] [Abstract][Full Text] [Related]
24. Aryl hydrocarbon receptor activation by cAMP vs. dioxin: divergent signaling pathways.
Oesch-Bartlomowicz B; Huelster A; Wiss O; Antoniou-Lipfert P; Dietrich C; Arand M; Weiss C; Bockamp E; Oesch F
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9218-23. PubMed ID: 15972329
[TBL] [Abstract][Full Text] [Related]
25. Toxicity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD).
Kociba RJ; Schwetz BA
Drug Metab Rev; 1982; 13(3):387-406. PubMed ID: 6213397
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of in vivo hepatic uptake and in vitro hepatic binding of [125I]2-lodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonist for the Ah receptor.
Poland A; Teitelbaum P; Glover E; Kende A
Mol Pharmacol; 1989 Jul; 36(1):121-7. PubMed ID: 2546046
[TBL] [Abstract][Full Text] [Related]
27. Integrated approach for evaluating species and interindividual differences in responsiveness to dioxins and structural analogs.
Clark G; Tritscher A; Bell D; Lucier G
Environ Health Perspect; 1992 Nov; 98():125-32. PubMed ID: 1336723
[TBL] [Abstract][Full Text] [Related]
28. Quantitative characterization of changes in bone geometry, mineral density and biomechanical properties in two rat strains with different Ah-receptor structures after long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Herlin M; Kalantari F; Stern N; Sand S; Larsson S; Viluksela M; Tuomisto JT; Tuomisto J; Tuukkanen J; Jämsä T; Lind PM; Håkansson H
Toxicology; 2010 Jun; 273(1-3):1-11. PubMed ID: 20403408
[TBL] [Abstract][Full Text] [Related]
29. Receptor mechanisms and dose-response models for the effects of dioxins.
Lucier GW; Portier CJ; Gallo MA
Environ Health Perspect; 1993 Apr; 101(1):36-44. PubMed ID: 8390353
[TBL] [Abstract][Full Text] [Related]
30. Evidence for a second pathway in the action mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Significance of Ah-receptor mediated activation of protein kinase under cell-free conditions.
Enan E; Matsumura F
Biochem Pharmacol; 1995 Jan; 49(2):249-61. PubMed ID: 7840803
[TBL] [Abstract][Full Text] [Related]
31. Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (525):1-198. PubMed ID: 17160103
[TBL] [Abstract][Full Text] [Related]
32. Relative differences in aryl hydrocarbon receptor-mediated response for 18 polybrominated and mixed halogenated dibenzo-p-dioxins and -furans in cell lines from four different species.
Olsman H; Engwall M; Kammann U; Klempt M; Otte J; Bavel Bv; Hollert H
Environ Toxicol Chem; 2007 Nov; 26(11):2448-54. PubMed ID: 17941736
[TBL] [Abstract][Full Text] [Related]
33. Expression of hepatic pyruvate carboxylase mRNA in C57BL/6J Ah(b/b) and congenic Ah((d/d)) mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Ilian MA; Sparrow BR; Ryu BW; Selivonchick DP; Schaup HW
J Biochem Toxicol; 1996; 11(1):51-6. PubMed ID: 8806052
[TBL] [Abstract][Full Text] [Related]
34. The immunotoxic effects of dual exposure to PCP and TCDD.
Chen HM; Lee YH; Chen RJ; Chiu HW; Wang BJ; Wang YJ
Chem Biol Interact; 2013 Nov; 206(2):166-74. PubMed ID: 24051191
[TBL] [Abstract][Full Text] [Related]
35. Toxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in developing red seabream (Pagrus major) embryo: an association of morphological deformities with AHR1, AHR2 and CYP1A expressions.
Yamauchi M; Kim EY; Iwata H; Shima Y; Tanabe S
Aquat Toxicol; 2006 Nov; 80(2):166-79. PubMed ID: 16987556
[TBL] [Abstract][Full Text] [Related]
36. Differential relative effect potencies of some dioxin-like compounds in human peripheral blood lymphocytes and murine splenic cells.
van Ede KI; Gaisch KP; van den Berg M; van Duursen MB
Toxicol Lett; 2014 Apr; 226(1):43-52. PubMed ID: 24472611
[TBL] [Abstract][Full Text] [Related]
37. Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains.
Viluksela M; Bager Y; Tuomisto JT; Scheu G; Unkila M; Pohjanvirta R; Flodström S; Kosma VM; Mäki-Paakkanen J; Vartiainen T; Klimm C; Schramm KW; Wärngård L; Tuomisto J
Cancer Res; 2000 Dec; 60(24):6911-20. PubMed ID: 11156390
[TBL] [Abstract][Full Text] [Related]
38. Carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in experimental models.
Knerr S; Schrenk D
Mol Nutr Food Res; 2006 Oct; 50(10):897-907. PubMed ID: 16977593
[TBL] [Abstract][Full Text] [Related]
39. Differences in acute toxicity syndromes of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin in rats.
Niittynen M; Simanainen U; Syrjälä P; Pohjanvirta R; Viluksela M; Tuomisto J; Tuomisto JT
Toxicology; 2007 Jun; 235(1-2):39-51. PubMed ID: 17448584
[TBL] [Abstract][Full Text] [Related]
40. Studies on the mechanism of action of halogenated aromatic hydrocarbons.
Poland A; Knutson J; Glover E
Clin Physiol Biochem; 1985; 3(2-3):147-54. PubMed ID: 2988846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
